Nov 28, 2015 at 14:06 | Source: PTI
Pazzta samples were collected from Nestle distributor - Sriji Traders at Mau on June 10 and were sent to a Lucknow-based government laboratory.
Nov 27, 2015 at 21:36 | Source: PTI
The court in its 106-page judgment also said that as Cipla "could not establish prima facie that suit patent was obvious" therefore, its plea for invalidating Roche's patent on the ground of 'obviousness', "fails".
Nov 24, 2015 at 14:56 | Source: CNBC-TV18
C Krishna Prasad, MD, Granules India says margins in contract research and manufacturing services (CRAMS) business is relatively high and expects 30-35 percent of capacity utilization in the same.
Nov 23, 2015 at 19:06 | Source: PTI
The product, which has been approved by Drug Controller General of India, is priced at nearly Rs 600 for 30 days therapy to a patient
Nov 23, 2015 at 09:12 | Source: PTI
The company has received approval from the US Food and Drug Administration (USFDA) to market Dutasteride capsules in the strength of 0.5 mg, Strides Shasun said in a regulatory filing.
Nov 21, 2015 at 16:01 | Source: Reuters
The settlement between a US unit of Swiss drugmaker Novartis AG, the federal government and more than 40 states concerns payments that the drug manufacturer paid between 2007 and 2012 to certain specialty pharmacies to entice them to recommend prescriptions to Medicaid and Medicare patients.
Nov 21, 2015 at 15:59 | Source: PTI
Quoting IMS data, Aurobindo Pharma said the approved product has an estimated market size of USD 80 million for the twelve months ended September 2015.
Nov 21, 2015 at 12:26 | Source: Moneycontrol.com
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Sildenafil Tablets, 20 mg (ANDA 203963). This product is expected to be launched by Q4 FY 2015-16.
Nov 18, 2015 at 20:53 | Source: IBNLive.com
Through IPDMS, data on production, import and pricing of scheduled and non-scheduled formulations can be assessed, analysed and used to generate reports.
Nov 18, 2015 at 16:08 | Source: PTI
Fondaparinux is a generic version of the anticoagulant drug Arixtra, which is approved in the US and Europe for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).